Skip to Main Content

Paper Details

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Nat Commun
1
2022
CEBPA, CSF3R, Myeloid lineage enhancers, acute myeloid leukemia
Author NameAffiliation
Theodore P BraunKnight Cancer Institute, Oregon Health & Science University
Theodore P BraunOregon Health & Science University
Mariam OkhovatKnight Cardiovascular Institute, Oregon Health & Science University
Cody CoblentzKnight Cancer Institute, Oregon Health & Science University
Cody CoblentzOregon Health & Science University
Sarah A CarrattKnight Cancer Institute, Oregon Health & Science University
Sarah A CarrattOregon Health & Science University
Amy FoleyKnight Cancer Institute, Oregon Health & Science University
Amy FoleyOregon Health & Science University
Zachary SchonrockKnight Cancer Institute, Oregon Health & Science University
Zachary SchonrockOregon Health & Science University
Brittany M CurtissKnight Cancer Institute, Oregon Health & Science University
Brittany M CurtissOregon Health & Science University
Kimberly A NevonenKnight Cardiovascular Institute, Oregon Health & Science University
Brett DavisKnight Cardiovascular Institute, Oregon Health & Science University
Brianna GarciaKnight Cancer Institute, Oregon Health & Science University
Brianna GarciaOregon Health & Science University
Dorian LaTochaKnight Cancer Institute, Oregon Health & Science University
Dorian LaTochaOregon Health & Science University
Benjamin R WeederOregon Health & Science University
Michal R GrzadkowskiOregon Health & Science University
Joseph EstabrookOregon Health & Science University
Hannah G ManningOregon Health & Science University
Kevin Watanabe-SmithKnight Cancer Institute, Oregon Health & Science University
Kevin Watanabe-SmithOregon Health & Science University
Sophia JengOregon Health & Science University
Jenny L SmithClinical Research Division, Fred Hutchinson Cancer Research Center
Amanda R LeontiClinical Research Division, Fred Hutchinson Cancer Research Center
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center
Shannon K McWeeneyKnight Cancer Institute, Oregon Health & Science University
Shannon K McWeeneyOregon Health & Science University
Cristina Di GenuaMRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital
Roy DrissenMRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital
Claus NerlovMRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Soheil MeshinchiUniversity of Washington
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center
Soheil MeshinchiUniversity of Washington
Lucia CarboneKnight Cardiovascular Institute, Oregon Health & Science University
Lucia CarboneOregon Health & Science University
Lucia CarboneOregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University
Brian J DrukerHoward Hughes Medical Institute
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University
Julia E MaxsonOregon Health & Science University
  • 1 - 47

Datasets